Rejoinder

DOI10.1002/BIMJ.200610258MaRDI QIDQ5122848zbMATH OpenOpenAlexFDO

Authors

Publication date 24 September 2020

Published in Biometrical Journal (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1002/bimj.200610258

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Adaptive designs from the viewpoint of an academic biostatistician
• Methodological developments vs. regulatory requirements
• Opening the adaptive toolbox
• Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians
• FDA's critical path initiative: a perspective on contributions of biostatistics

Cited in

(16)

• Ephedra
• Rejoinder
• Rejoinder
• Rejoinder
• FDA's critical path initiative: a perspective on contributions of biostatistics
• Adaptive designs from the viewpoint of an academic biostatistician
• Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians
• Opening the adaptive toolbox
• Methodological developments vs. regulatory requirements
• Rejoinder
• Rejoinder
• Rejoinder
• Rejoinder
• Rejoinder
• Rejoinder
• Rejoinder to Discussions on “Approval policies for modifications to machine learning‐based software as a medical device: A study of bio‐creep”

This page was built for publication: Rejoinder

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5122848)